Type 2 diabetes mellitus

By Ralph DeFronzo, E. Ferrannini, Leif Groop, R. Henry, W. Herman, Jens J. Holst, Frank B. Hu, C. R. Kahn, I. Raz, Gerald I. Shulman and 3 more. Nature Reviews Disease Primers, 2015

2,875 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/9826997ad233ac10f32ccd21e5d4b612f16005e7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. G. Svegliati-Baroni
2. F. Marra

In Molecular Biology

1. G. Svegliati-Baroni
2. F. Marra

Citations in the corpus

• The PI3K/AKT pathway in obesity and type 2 diabetes (2018, background): “Unfortunately, these treatments currently cannot ensure long-term glycaemic control or reverse the progress [4].”
• Lipotoxicity and the gut-liver axis in NASH pathogenesis. (2018, background): “stimulates gluconeogenesis, glycogenolysis, and net hepatic glucose output [114].”
• Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation (2017, background): “Obesity can modify one or both of these variables (73).”